Human prostate specific g-protein receptor hpraj70
CA 2422642 A1 · Owner: Ruben, Steven M. · Inventors: Li, Yi; Soppet, Daniel R.; Rosen, Craig A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor overexpressed in prostate cancer. More specifically, the invention relates to PSGR polynucleotides and the polypeptides encoded by these polynucleotides and the use of PSGR , polynucleotides and polypeptides for detecting disorders of the reproductive system, including disorders of the prostate particularly the presence of , cancer. This invention relates to PSGR polynucleotides and polypeptides as well as vectors, host cells, antibodies directed to PSGR polynucleotides and polypeptides and recombinant and synthetic methods for producing the same. Also provided are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.